Litcius/Paper detail

Selecting coronavirus disease 2019 patients with negligible risk of progression: early experience from non-hospital isolation facility in Korea

Pyoeng Gyun Choe, EunKyo Kang, Sun Young Lee, Boram Oh, Dahae Im, Hyo‐Yeon Lee, Hyemin Jung, Chang Kyung Kang, Min Sun Kim, Wan Beom Park, Eun Hwa Choi, Belong Cho, Myoung‐don Oh, Nam Joong Kim

2020The Korean Journal of Internal Medicine25 citationsDOIOpen Access PDF

Abstract

BACKGROUND/AIMS: As the novel coronavirus (coronavirus disease 2019 [COVID-19]) outbreak progresses rapidly, staying home is recommended for suspected patients; however, the safety of this recommendation is uncertain. In Korea, non-hospital facilities called "living and treatment centers (LTCs)" have been established since 5 March 2020. The LTCs provided a unique opportunity to evaluate the safety of selection criteria for low-risk groups. METHODS: Between 5 March and 9 April 2020, patients with COVID-19 who met the following criteria were admitted to the LTC; alert, age below 65 years old, no underlying disease or well-controlled underlying disease, body temperature below 38.0°C, whether taking antipyretics or not, and no dyspnea. Patients were closely observed by doctors or nurses' interviews twice a day and transferred to hospitals when symptoms worsened. RESULTS: A total of 113 patients were admitted to the LTC; 52.2% were female, with a median age of 25 years (interquartile range, 21.5 to 39.5). Of 113 patients, 54 (47.8%) were asymptomatic at diagnosis, and 15 (13.3%) had no symptoms until they were released from isolation. During the follow-up period, two (1.8%) patients were transferred to a hospital but did not progress to severe status during hospitalization. CONCLUSION: The risk of progression was negligible in COVID-19 patients who met the admission criteria for LTC at the time of diagnosis. LTCs could be a safe alternative considering shortage of hospital beds.

Topics & Concepts

MedicineInterquartile rangeAsymptomaticCoronavirus disease 2019 (COVID-19)Isolation (microbiology)OutbreakDiseaseEmergency medicinePandemicPediatricsSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Internal medicineInfectious disease (medical specialty)MicrobiologyVirologyBiologyCOVID-19 and healthcare impactsCOVID-19 Clinical Research StudiesCOVID-19 epidemiological studies